Company Overview - ClearPoint Neuro enables cell, gene, and device therapies by offering precise navigation to the brain and spine[6] - The company's platform includes clinical products for neurosurgeons and drug development services for BioPharma partners[6] - ClearPoint Neuro has built a complete drug delivery ecosystem over 15+ years, including navigation solutions, predictive modeling, delivery devices, infusion monitoring software, and clinical case support[8] - The company has 100+ active global centers and 60+ partners across 20+ indications[8] Market Opportunity - The company estimates a current portfolio provides access to a ≈$500 million market opportunity[8] - ClearPoint Neuro sees a $10 billion potential diversified market[9, 117] - Neurological diseases cost Americans nearly $800 billion annually[10] Financial Performance and Growth - The company's 2024 revenue was $31.4 million[51] - The company had $12.4 million in cash and cash equivalents as of March 31, 2025, excluding $33.5 million gross proceeds received on May 12, 2025[51, 52] - The gross margin was 61% for the trailing twelve months[51] - The company estimates 2025 revenue between $36 million and $41 million[52]